VYGR
Voyager Therapeutics, Inc.Company with tickers: VYGR
CIK
1640266
CUSIP
92915B106
Shares Outstanding
59,599,375
Price
Holdings
Short Volume
Short Interest
Fails to Deliver
SEC Filings
Earnings Calls
Insider Trading
Congress Trades
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2026-04-02 | Sandrock Alfred | Director, President and CEO | Sell | 11,511 |
| 2026-04-01 | Shiferman Gregory L. | SVP and General Counsel | Award | 50,000 |
| 2026-02-24 | Sandrock Alfred | Director, President and CEO | Sell | 14,197 |
| 2026-02-24 | Swartz Robin | COO & CBO | Sell | 6,458 |
| 2026-02-24 | Jorgensen Nathan D. | Chief Financial Officer | Sell | 4,668 |
| 2026-02-24 | Carter Todd Alfred | Chief Scientific Officer | Sell | 4,174 |
| 2026-02-18 | Swartz Robin | COO & CBO | Sell | 3,882 |
| 2026-02-18 | Carter Todd Alfred | Chief Scientific Officer | Sell | 3,301 |
| 2026-02-18 | Sandrock Alfred | Director, President and CEO | Sell | 11,732 |
| 2026-02-10 | Swartz Robin | COO & CBO | Sell | 4,569 |
| 2026-02-10 | Sandrock Alfred | Director, President and CEO | Sell | 12,192 |
| 2026-02-10 | Carter Todd Alfred | Chief Scientific Officer | Sell | 3,525 |
| 2026-02-06 | Carter Todd Alfred | Chief Scientific Officer | Award | 33,000 |
| 2026-02-06 | Carter Todd Alfred | Chief Scientific Officer | Award | 154,000 |
| 2026-02-06 | Swartz Robin | COO & CBO | Award | 45,000 |
| 2026-02-06 | Swartz Robin | COO & CBO | Award | 210,000 |
| 2026-02-06 | Sandrock Alfred | Director, President and CEO | Award | 86,250 |
| 2026-02-06 | Sandrock Alfred | Director, President and CEO | Award | 402,500 |
| 2026-02-06 | Jorgensen Nathan D. | Chief Financial Officer | Award | 32,250 |
| 2026-02-06 | Jorgensen Nathan D. | Chief Financial Officer | Award | 150,500 |
| 2026-02-06 | Ferguson Toby | Chief Medical Officer | Award | 210,000 |
| 2026-02-06 | Ferguson Toby | Chief Medical Officer | Award | 45,000 |
| 2026-01-06 | Shiferman Gregory L. | SVP and General Counsel | Award | 100,000 |
| 2026-01-06 | Shiferman Gregory L. | SVP and General Counsel | Other | 0 |
| 2025-10-03 | Jorgensen Nathan D. | Chief Financial Officer | Sell | 7,666 |
| 2025-08-18 | Ferguson Toby | Chief Medical Officer | Sell | 19,000 |
| 2025-06-03 | PIERCE GLENN | Director | Award | 24,000 |
| 2025-06-03 | Higgins Michael J | Director | Award | 24,000 |
| 2025-06-03 | Colon Grace | Director | Award | 24,000 |
| 2025-06-03 | Vitale Nancy | Director | Award | 24,000 |
| 2025-06-03 | SCANGOS GEORGE A | Director | Award | 24,000 |
| 2025-06-03 | MACKEY CATHERINE J | Director | Award | 24,000 |
| 2025-06-03 | Onyia Jude | Chief Scientific Officer | Award | 24,000 |
| 2025-06-03 | Hyman Steven | Director | Award | 24,000 |
| 2025-06-03 | GERAGHTY JAMES A | Director | Award | 24,000 |
| 2025-04-02 | Ferguson Toby | Chief Medical Officer | Sell | 10,086 |
| 2025-04-02 | Sandrock Alfred | Director, President and CEO | Sell | 10,885 |
| 2025-02-21 | Fahey Sandell Jacquelyn | Chief Legal Officer | Award | 41,500 |
| 2025-02-21 | Fahey Sandell Jacquelyn | Chief Legal Officer | Award | 83,000 |
| 2025-02-21 | Carter Todd Alfred | Chief Scientific Officer | Award | 46,000 |
| 2025-02-21 | Carter Todd Alfred | Chief Scientific Officer | Award | 92,000 |
| 2025-02-21 | Ferguson Toby | Chief Medical Officer | Award | 63,000 |
| 2025-02-21 | Ferguson Toby | Chief Medical Officer | Award | 126,000 |
| 2025-02-21 | Sandrock Alfred | Director, President and CEO | Award | 290,000 |
| 2025-02-21 | Sandrock Alfred | Director, President and CEO | Award | 145,000 |
| 2025-02-21 | Swartz Robin | COO & CBO | Award | 142,500 |
| 2025-02-21 | Swartz Robin | COO & CBO | Award | 71,250 |
| 2025-02-21 | Jorgensen Nathan D. | Chief Financial Officer | Award | 103,000 |
| 2025-02-21 | Jorgensen Nathan D. | Chief Financial Officer | Award | 51,500 |
| 2025-02-20 | Carter Todd Alfred | Chief Scientific Officer | Sell | 3,305 |
| 2025-02-20 | Sandrock Alfred | Director, President and CEO | Sell | 11,702 |
| 2025-02-20 | Swartz Robin | COO & CBO | Sell | 3,894 |
| 2025-02-11 | Carter Todd Alfred | Chief Scientific Officer | Sell | 5,413 |
| 2025-02-11 | Swartz Robin | COO & CBO | Sell | 6,950 |
| 2025-02-11 | Sandrock Alfred | Director, President and CEO | Sell | 16,644 |
| 2025-02-11 | Fahey Sandell Jacquelyn | Chief Legal Officer | Sell | 4,358 |
| 2025-01-14 | Carter Todd Alfred | Chief Scientific Officer | Sell | 1,191 |
| 2025-01-14 | Swartz Robin | COO & CBO | Sell | 3,087 |
| 2024-12-23 | Swartz Robin | COO & CBO | Sell | 6,500 |
| 2024-10-02 | Fahey Sandell Jacquelyn | Chief Legal Officer | Sell | 5,999 |
| 2024-10-01 | Jorgensen Nathan D. | Chief Financial Officer | Award | 80,000 |
| 2024-07-08 | Jorgensen Nathan D. | Chief Financial Officer | Other | 0 |
| 2024-07-08 | Jorgensen Nathan D. | Chief Financial Officer | Award | 200,000 |
| 2024-06-05 | Vitale Nancy | Director | Award | 24,000 |
| 2024-06-05 | PIERCE GLENN | Director | Award | 24,000 |
| 2024-06-05 | Onyia Jude | Chief Scientific Officer | Award | 24,000 |
| 2024-06-05 | Colon Grace | Director | Award | 24,000 |
| 2024-06-05 | MACKEY CATHERINE J | Director | Award | 24,000 |
| 2024-06-05 | Hyman Steven | Director | Award | 24,000 |
| 2024-06-05 | SCANGOS GEORGE A | Director | Award | 24,000 |
| 2024-06-05 | Higgins Michael J | Director | Award | 24,000 |
| 2024-06-05 | GERAGHTY JAMES A | Director | Award | 24,000 |
| 2024-04-02 | Swartz Robin | COO & CBO | Sell | 1,357 |
| 2024-04-02 | Sandrock Alfred | Director, President and CEO | Sell | 12,115 |
| 2024-04-01 | Ferguson Toby | Chief Medical Officer | Award | 105,000 |
| 2024-03-25 | Ferguson Toby | Chief Medical Officer | Other | 0 |
| 2024-03-25 | Ferguson Toby | Chief Medical Officer | Award | 210,000 |
| 2024-02-21 | Swartz Robin | COO & CBO | Sell | 3,966 |
| 2024-02-21 | PFREUNDSCHUH PETER P. | Chief Financial Officer | Sell | 3,764 |
| 2024-02-21 | Sandrock Alfred | Director, President and CEO | Sell | 13,033 |
| 2024-02-21 | Carter Todd Alfred | Chief Scientific Officer | Sell | 3,365 |
| 2024-02-20 | Carter Todd Alfred | Chief Scientific Officer | Sell | 602 |
| 2024-02-09 | Fahey Sandell Jacquelyn | Chief Legal Officer | Award | 31,000 |
| 2024-02-09 | Fahey Sandell Jacquelyn | Chief Legal Officer | Award | 62,000 |
| 2024-02-09 | Carter Todd Alfred | Chief Scientific Officer | Award | 38,500 |
| 2024-02-09 | Carter Todd Alfred | Chief Scientific Officer | Award | 77,000 |
| 2024-02-09 | Sandrock Alfred | Director, President and CEO | Award | 260,000 |
| 2024-02-09 | Sandrock Alfred | Director, President and CEO | Award | 130,000 |
| 2024-02-09 | Swartz Robin | COO & CBO | Award | 100,000 |
| 2024-02-09 | Swartz Robin | COO & CBO | Award | 50,000 |
| 2024-02-09 | PFREUNDSCHUH PETER P. | Chief Financial Officer | Award | 60,000 |
| 2024-02-09 | PFREUNDSCHUH PETER P. | Chief Financial Officer | Award | 30,000 |
| 2024-01-17 | Swartz Robin | COO & CBO | Sell | 2,543 |
| 2024-01-17 | Carter Todd Alfred | Chief Scientific Officer | Sell | 1,266 |
| 2023-10-03 | PFREUNDSCHUH PETER P. | Chief Financial Officer | Sell | 13,567 |
| 2023-10-01 | Fahey Sandell Jacquelyn | Chief Legal Officer | Award | 61,000 |
| 2023-09-15 | Carter Todd Alfred | Chief Scientific Officer | Sell | 10,500 |
| 2023-09-15 | Carter Todd Alfred | Chief Scientific Officer | Convert | 5,000 |
| 2023-09-15 | Carter Todd Alfred | Chief Scientific Officer | Convert | 5,000 |
| 2023-07-10 | Fahey Sandell Jacquelyn | Chief Legal Officer | Other | 0 |